Page last updated: 2024-08-17

prednisone and azd8186

prednisone has been researched along with azd8186 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Baird, RD; Barry, ST; Choudhury, AD; Colebrook, S; Cook, N; de Bono, JS; de Bruin, EC; García-Carbacho, J; Hansen, AR; Hawkins, G; Heath, EI; Higano, CS; Klinowska, T; Linch, M; Maroj, B; Martin-Liberal, J; Moorthy, G; Mortimer, PG; Moschetta, M; Nikolaou, M; Quintela-Fandino, M; Rathkopf, DE; Sainsbury, L; Shapiro, GI; Siu, LL; Wisinski, KB	1

Trials

1 trial(s) available for prednisone and azd8186

Article	Year
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, 06-01, Volume: 28, Issue:11 Topics: Abiraterone Acetate; Aniline Compounds; Carcinoma, Non-Small-Cell Lung; Chromones; Humans; Lung Neoplasms; Male; Neoplasms; Prednisone; Prostate-Specific Antigen; Prostatic Neoplasms	2022

Article

Year

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, 06-01, Volume: 28, Issue:11

Topics: Abiraterone Acetate; Aniline Compounds; Carcinoma, Non-Small-Cell Lung; Chromones; Humans; Lung Neoplasms; Male; Neoplasms; Prednisone; Prostate-Specific Antigen; Prostatic Neoplasms

2022